This Is Why cover image

Why are young people still dying from meningitis?

This Is Why

00:00

Why MenB isn't routine for teens

Thomas Moore discusses vaccine development cost, JCVI cost-effectiveness decisions, and policy trade-offs.

Play episode from 12:57
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app